Interparfums Valuation

Is 0IUJ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0IUJ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0IUJ (€39.75) is trading below our estimate of fair value (€45.18)

Significantly Below Fair Value: 0IUJ is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0IUJ?

Key metric: As 0IUJ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0IUJ. This is calculated by dividing 0IUJ's market cap by their current earnings.
What is 0IUJ's PE Ratio?
PE Ratio27.2x
Earnings€110.80m
Market Cap€3.02b

Price to Earnings Ratio vs Peers

How does 0IUJ's PE Ratio compare to its peers?

The above table shows the PE ratio for 0IUJ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average34.7x
W7L Warpaint London
24x13.5%UK£411.5m
APN Applied Nutrition
18.7xn/aUK£350.5m
HLN Haleon
28.3x10.5%UK£34.2b
VLG Venture Life Group
67.6x67.1%UK£50.2m
0IUJ Interparfums
27.2x10.3%€3.0b

Price-To-Earnings vs Peers: 0IUJ is good value based on its Price-To-Earnings Ratio (27.2x) compared to the peer average (34.7x).


Price to Earnings Ratio vs Industry

How does 0IUJ's PE Ratio compare vs other companies in the European Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
0IUJ 27.2xIndustry Avg. 23.4xNo. of Companies5PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0IUJ is expensive based on its Price-To-Earnings Ratio (27.2x) compared to the European Personal Products industry average (23.4x).


Price to Earnings Ratio vs Fair Ratio

What is 0IUJ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0IUJ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio27.2x
Fair PE Ratio18x

Price-To-Earnings vs Fair Ratio: 0IUJ is expensive based on its Price-To-Earnings Ratio (27.2x) compared to the estimated Fair Price-To-Earnings Ratio (18x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0IUJ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€39.75
€48.80
+22.8%
12.9%€58.00€36.00n/a10
Dec ’25€39.60
€48.90
+23.5%
13.0%€58.00€36.00n/a10
Nov ’25€40.95
€50.32
+22.9%
13.9%€61.20€36.00n/a10
Oct ’25€44.03
€51.73
+17.5%
13.5%€61.20€36.00n/a10
Sep ’25€45.30
€52.13
+15.1%
12.8%€61.20€36.00n/a10
Aug ’25€47.05
€52.13
+10.8%
12.8%€61.20€36.00n/a10
Jul ’25€39.05
€53.94
+38.1%
7.2%€61.82€49.09n/a9
Jun ’25€44.23
€54.44
+23.1%
7.8%€61.82€49.09n/a9
May ’25€43.23
€54.44
+25.9%
7.8%€61.82€49.09n/a9
Apr ’25€47.30
€53.01
+12.1%
9.5%€61.82€46.36n/a8
Mar ’25€46.91
€51.99
+10.8%
11.4%€61.82€45.45n/a8
Feb ’25€44.54
€51.25
+15.1%
12.1%€61.82€45.45n/a8
Jan ’25€45.94
€52.50
+14.3%
15.0%€68.18€45.45€40.358
Dec ’24€45.41
€52.50
+15.6%
15.0%€68.18€45.45€39.608
Nov ’24€40.88
€61.59
+50.7%
20.4%€81.82€45.45€40.957
Oct ’24€47.90
€64.19
+34.0%
16.7%€81.82€46.36€44.037
Sep ’24€55.00
€65.75
+19.5%
13.7%€81.82€52.73€45.307
Aug ’24€58.75
€64.36
+9.5%
12.2%€75.45€50.41€47.057
Jul ’24€59.31
€62.09
+4.7%
10.8%€71.90€50.41€39.057
Jun ’24€56.11
€61.16
+9.0%
9.6%€71.90€50.41€44.238
May ’24€59.39
€58.88
-0.9%
7.9%€66.12€50.41€43.238
Apr ’24€57.02
€54.19
-5.0%
3.6%€57.02€50.41€47.307
Mar ’24€54.96
€52.27
-4.9%
7.2%€56.20€44.63€46.916
Feb ’24€49.84
€50.48
+1.3%
6.7%€54.55€44.63€44.546
Jan ’24€46.16
€46.69
+1.2%
5.2%€50.41€42.98€45.946

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 02:32
End of Day Share Price 2025/01/03 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Interparfums SA is covered by 24 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Fraser DonlonBerenberg
Mourad LahmidiBNP Paribas Exane
Claire DerayBNP Paribas Fortis